BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

  October 28, 2026

   · 

  7 min read
• Press Releases

  Sofwave to Participate in Upcoming November 2026 Investor Conferences

  October 28, 2026

   · 

  1 min read
• Press Releases

  Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

  October 28, 2026

   · 

  9 min read
• Press Releases

  Immutep Receives A$2.16 million French R&D Tax Incentive

  October 28, 2026

   · 

  2 min read
• Press Releases

  Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301

  October 28, 2026

   · 

  11 min read
• Press Releases

  Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate

  October 28, 2026

   · 

  4 min read
• Press Releases

  PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections

  October 28, 2026

   · 

  10 min read
• Press Releases

  Transpharmation Ltd. Announces Strategic Acquisition of OrganoTherapeutics SARL

  October 28, 2026

   · 

  5 min read
• Press Releases

  Boehringer Ingelheim Establishes Metabolic Matters Steering Committee to Advance More Connected Care for Obesity and Related Liver Diseases

  October 28, 2026

   · 

  5 min read
• Press Releases

  Coya Therapeutics to Present Neurofilament Light Chain (NfL) Biomarker Stratification Methodology in the ALSTARS Trial to Minimize the Impact of Heterogeneity in ALS Clinical Trials at the 2026 Annual NEALS Meeting

  October 28, 2026

   · 

  7 min read